Trial: 201808007

AGCT1532 – A randomized phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumors

Phase

III

Principal Investigator

Hayashi, Robert

Disease Site

Other Male Genital; Ovary; Soft Tissue

Learn more about this study at: clinicaltrials.gov